0001127602-22-021087.txt : 20220816
0001127602-22-021087.hdr.sgml : 20220816
20220816163356
ACCESSION NUMBER: 0001127602-22-021087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20220816
DATE AS OF CHANGE: 20220816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KROLL MARK W
CENTRAL INDEX KEY: 0001259254
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 221170598
MAIL ADDRESS:
STREET 1: PO BOX 23
CITY: CRYSTAL BAY
STATE: MN
ZIP: 55323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0401
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-08-15
0000313143
HAEMONETICS CORP
HAE
0001259254
KROLL MARK W
125 SUMMER STREET
BOSTON
MA
02110
1
Common Stock
2022-08-15
4
S
0
8016
73.71
D
16231
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.41 to $74.25, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This number includes unvested restricted stock units previously reported.
/s/ Thomas V. Powers, attorney-in-fact for Dr. Kroll
2022-08-16